Tefron Statistics
Total Valuation
Tefron has a market cap or net worth of 94.37 million. The enterprise value is 105.32 million.
| Market Cap | 94.37M |
| Enterprise Value | 105.32M |
Important Dates
The next estimated earnings date is Friday, May 23, 2025.
| Earnings Date | May 23, 2025 |
| Ex-Dividend Date | Apr 1, 2025 |
Share Statistics
Tefron has 12.58 million shares outstanding. The number of shares has increased by 3.12% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 12.58M |
| Shares Change (YoY) | +3.12% |
| Shares Change (QoQ) | -5.13% |
| Owned by Insiders (%) | 0.16% |
| Owned by Institutions (%) | 10.73% |
| Float | 4.06M |
Valuation Ratios
The trailing PE ratio is 6.64.
| PE Ratio | 6.64 |
| Forward PE | n/a |
| PS Ratio | 0.32 |
| PB Ratio | 1.23 |
| P/TBV Ratio | 1.38 |
| P/FCF Ratio | 4.19 |
| P/OCF Ratio | 3.05 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.43, with an EV/FCF ratio of 4.67.
| EV / Earnings | 6.97 |
| EV / Sales | 0.36 |
| EV / EBITDA | 3.43 |
| EV / EBIT | 4.56 |
| EV / FCF | 4.67 |
Financial Position
The company has a current ratio of 1.74, with a Debt / Equity ratio of 0.16.
| Current Ratio | 1.74 |
| Quick Ratio | 0.92 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | 0.39 |
| Debt / FCF | 0.54 |
| Interest Coverage | 6.70 |
Financial Efficiency
Return on equity (ROE) is 21.59% and return on invested capital (ROIC) is 16.61%.
| Return on Equity (ROE) | 21.59% |
| Return on Assets (ROA) | 9.94% |
| Return on Invested Capital (ROIC) | 16.61% |
| Return on Capital Employed (ROCE) | 26.45% |
| Revenue Per Employee | 148,641 |
| Profits Per Employee | 7,644 |
| Employee Count | 1,977 |
| Asset Turnover | 2.02 |
| Inventory Turnover | 4.37 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +37.62% in the last 52 weeks. The beta is 0.95, so Tefron's price volatility has been similar to the market average.
| Beta (5Y) | 0.95 |
| 52-Week Price Change | +37.62% |
| 50-Day Moving Average | 7.50 |
| 200-Day Moving Average | 7.33 |
| Relative Strength Index (RSI) | 100.00 |
| Average Volume (20 Days) | 0 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Tefron had revenue of 293.86 million and earned 15.11 million in profits. Earnings per share was 1.13.
| Revenue | 293.86M |
| Gross Profit | 66.48M |
| Operating Income | 23.11M |
| Pretax Income | 19.56M |
| Net Income | 15.11M |
| EBITDA | 28.28M |
| EBIT | 23.11M |
| Earnings Per Share (EPS) | 1.13 |
Balance Sheet
The company has 6.80 million in cash and 12.09 million in debt, giving a net cash position of -5.29 million or -0.42 per share.
| Cash & Cash Equivalents | 6.80M |
| Total Debt | 12.09M |
| Net Cash | -5.29M |
| Net Cash Per Share | -0.42 |
| Equity (Book Value) | 76.79M |
| Book Value Per Share | 6.09 |
| Working Capital | 46.07M |
Cash Flow
In the last 12 months, operating cash flow was 30.91 million and capital expenditures -8.36 million, giving a free cash flow of 22.55 million.
| Operating Cash Flow | 30.91M |
| Capital Expenditures | -8.36M |
| Free Cash Flow | 22.55M |
| FCF Per Share | 1.79 |
Margins
Gross margin is 22.62%, with operating and profit margins of 7.86% and 5.14%.
| Gross Margin | 22.62% |
| Operating Margin | 7.86% |
| Pretax Margin | 6.66% |
| Profit Margin | 5.14% |
| EBITDA Margin | 9.62% |
| EBIT Margin | 7.86% |
| FCF Margin | 7.67% |
Dividends & Yields
This stock pays an annual dividend of 0.16, which amounts to a dividend yield of 2.13%.
| Dividend Per Share | 0.16 |
| Dividend Yield | 2.13% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 13.20% |
| Buyback Yield | -3.12% |
| Shareholder Yield | -0.99% |
| Earnings Yield | 16.01% |
| FCF Yield | 23.89% |
Stock Splits
The last stock split was on January 22, 2009. It was a reverse split with a ratio of 0.1.
| Last Split Date | Jan 22, 2009 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
Tefron has an Altman Z-Score of 3.06.
| Altman Z-Score | 3.06 |
| Piotroski F-Score | n/a |